thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33423638-4BBD0691-297D-48A9-96A2-F1E6F7CAFC85
Q33423638-4BBD0691-297D-48A9-96A2-F1E6F7CAFC85
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33423638-4BBD0691-297D-48A9-96A2-F1E6F7CAFC85
Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.
P2860
Q33423638-4BBD0691-297D-48A9-96A2-F1E6F7CAFC85
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33423638-4BBD0691-297D-48A9-96A2-F1E6F7CAFC85
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
87fd85a70e3ef48e0a7303cbd22f50b64a09f095
P2860
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.